Sangamo Therapeutics, Inc.Sangamo Therapeutics, Inc.Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

No trades
See on Supercharts

Price target

5.800.000.00%
The 5 analysts offering 1 year price forecasts for SGMO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to SGMO in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SGMO EPS for the last quarter is 0.04 USD despite the estimation of −0.02 USD. In the next quarter EPS is expected to reach 0.22 USD. Track more of Sangamo Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Sangamo Therapeutics, Inc. revenue is expected to reach ‪40.00 M‬ USD. Check out Sangamo Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SGMO price target is 5.80 USD with a max estimate of 10.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch Sangamo Therapeutics, Inc. stock price chart and keep track of the current situation with SGMO news and stock market news.
We've gathered opinions of 7 analysts rating SGMO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.